EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Gut Microbiome Advances Precision Medicine and Diagnostics for Inflammatory Bowel Diseases

Walaa K Mousa, Aya Al Ali iD

International Journal of Molecular Sciences · 19.10.2024 · 25 (20) · 11259

DOI: 10.3390/ijms252011259 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.10.2024. Verfasst von Walaa K Mousa und 1 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Al Ain University of Science and Technology, Abu Dhabi 64141, United Arab Emirates. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Gastrointestinal Microbiome, Precision Medicine, Probiotics. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 209 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut microbiome emerges as an integral component of precision medicine because of its signature variability among individuals and its plasticity, which enables personalized therapeutic interventions, especially when integrated with other multiomics data. This promise is further fueled by advances in next-generation sequencing and metabolomics, which allow in-depth high-precision profiling of microbiome communities, their genetic contents, and secreted chemistry. This knowledge has advanced our understanding of our microbial partners, their interaction with cellular targets, and their implication in human conditions such as inflammatory bowel disease (IBD). This explosion of microbiome data inspired the development of next-generation therapeutics for treating IBD that depend on manipulating the gut microbiome by diet modulation or using live products as therapeutics. The current landscape of artificial microbiome therapeutics is not limited to probiotics and fecal transplants but has expanded to include community consortia, engineered probiotics, and defined metabolites, bypassing several limitations that hindered rapid progress in this field such as safety and regulatory issues. More integrated research will reveal new therapeutic targets such as enzymes or receptors mediating interactions between microbiota-secreted molecules that drive or modulate diseases. With the shift toward precision medicine and the enhanced integration of host genetics and polymorphism in treatment regimes, the following key questions emerge: How can we effectively implement microbiomics to further personalize the treatment of diseases like IBD, leveraging proven and validated microbiome links? Can we modulate the microbiome to manage IBD by altering the host immune response? In this review, we discuss recent advances in understanding the mechanism underpinning the role of gut microbes in driving or preventing IBD. We highlight developed targeted approaches to reverse dysbiosis through precision editing of the microbiome. We analyze limitations and opportunities while defining the specific clinical niche for this innovative therapeutic modality for the treatment, prevention, and diagnosis of IBD and its potential implication in precision medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Inflammatory Bowel DiseasesGastrointestinal MicrobiomePrecision MedicineProbioticsHumansFecal Microbiota TransplantationAnimalsMetabolomics

Stichwörter der Autor:innen

IBDdiagnosticsgut microbiotalive therapeuticsmicrobiome editingprecision medicine

Autor:innen und Institutionen

  • College of Pharmacy, Al Ain University of Science and Technology, Abu Dhabi 64141, United Arab Emirates.
  • College of Pharmacy, Mansoura University, Mansoura 35516, Egypt.
  • AAU Health and Biomedical Research Center, Al Ain University, Abu Dhabi 112612, United Arab Emirates.

ORCID-Profile: Aya Al Ali

Zitieren

APA

Mousa, W. K., & Al Ali, A. (2024). The Gut Microbiome Advances Precision Medicine and Diagnostics for Inflammatory Bowel Diseases. International Journal of Molecular Sciences, 25(20), 11259. https://doi.org/10.3390/ijms252011259

Vancouver

Mousa WK, Al Ali A. The Gut Microbiome Advances Precision Medicine and Diagnostics for Inflammatory Bowel Diseases. International Journal of Molecular Sciences. 2024;25(20):11259. doi:10.3390/ijms252011259

BibTeX
@article{Mousa2024,
  author = {Mousa, Walaa K and Al Ali, Aya},
  title = {The Gut Microbiome Advances Precision Medicine and Diagnostics for Inflammatory Bowel Diseases},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {20},
  pages = {11259},
  doi = {10.3390/ijms252011259}
}
Kostenlos starten →